Lexeo Therapeutics, Inc. (LXEO) Total Liabilities (2022 - 2023)
Lexeo Therapeutics' Total Liabilities history spans 2 years, with the latest figure at $32.5 million for Q3 2023.
- For Q3 2023, Total Liabilities fell 67.17% year-over-year to $32.5 million; the TTM value through Sep 2023 reached $32.5 million, down 67.17%, while the annual FY2022 figure was $25.0 million, N/A changed from the prior year.
- Total Liabilities for Q3 2023 was $32.5 million at Lexeo Therapeutics, down from $143.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $143.6 million in Q2 2023 and bottomed at $25.0 million in Q4 2022.